Alcohol use, vascular disease, and lipid-lowering drugs

The Journal of Pharmacology and Experimental Therapeutics
Genovefa D KolovouD P Mikhailidis

Abstract

Many epidemiological and clinical studies have shown that light-to-moderate alcohol (Alc) consumption is associated with reduced risk of coronary heart disease (CHD) and total mortality in middle-aged and elderly men and women. The plausible mechanisms for the putative cardioprotective effects include increased levels of high-density lipoprotein cholesterol, prevention of clot formation, reduced platelet aggregation, promotion of blood clot dissolution, and lowering of plasma lipoprotein (a) concentration. Individuals who need to be treated with lipid-lowering drugs, such as dyslipidemic or CHD patients, may benefit from these effects of Alc. Because hypolipidemic treatment is usually continued for life, an important issue is the suitability of Alc consumption in these patients. In the present review, the beneficial effects of Alc consumption on CHD risk, its side effects, and its safety and suitability when coadministered with hypolipidemic drugs are discussed.

References

Nov 19, 1976·Biochimica Et Biophysica Acta·M F SorrellA J Barak
Aug 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S KamimuraH Tsukamoto
Aug 30, 1991·Biochemical and Biophysical Research Communications·Y TereliusM Ingelman-Sundberg
Oct 1, 1987·Journal of Clinical Gastroenterology·G L Clementz, A W Holmes
Feb 1, 1983·Southern Medical Journal·D J PattersonD Y Graham
Feb 1, 1983·Annals of Internal Medicine·A J Greenspon, S F Schaal
Jun 1, 1983·International Journal of Epidemiology·D KozarevicW J Zukel
Jul 13, 1995·The American Journal of Cardiology·J W SmitD W Erkelens
May 1, 1995·Hypertension·M W GillmanC H Hennekens
Jan 1, 1995·Journal of Gastroenterology and Hepatology·R S McCuskeyB Urbaschek
Dec 1, 1996·Alcoholism, Clinical and Experimental Research·S TsukamotoT Nagoya
May 1, 1997·Clinical and Experimental Pharmacology & Physiology·R Scott
Aug 14, 1998·Industrial Health·K NakamuraS Nakano
Nov 4, 1998·Alcoholism, Clinical and Experimental Research·S Andréasson
Nov 24, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·H E Bays, C A Dujovne
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·E S Ginsburg
Oct 28, 1999·The American Journal of Clinical Nutrition·S Q SilerM K Hellerstein
Jan 15, 2000·Journal of the American College of Cardiology·J M GazianoJ E Buring
Feb 24, 2000·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·I DupontD Lucas
Jun 19, 2001·Alcoholism, Clinical and Experimental Research·M Tsutsumi And, S Takase
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Dharam P Agarwal
Jan 11, 2003·The Journal of Biological Chemistry·Alan WiseNicholas B Pike
Apr 16, 2003·Zeitschrift für Gastroenterologie·F StickelD Schuppan
Sep 18, 2003·Addiction Biology·Armin Imhof, Wolfgang Koenig
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michael BöhmUlrich Laufs
Jan 27, 2004·Cleveland Clinic Journal of Medicine·Mark W Russo, Ira M Jacobson
Apr 9, 2004·The Proceedings of the Nutrition Society·Lisa M Hines
Jun 9, 2004·Lancet·Fredrik Karpe, Keith N Frayn
Jan 11, 2005·World Journal of Gastroenterology : WJG·Hafize UzunSafiye Kaya
Apr 19, 2005·Methods and Findings in Experimental and Clinical Pharmacology·G D KolovouD V Cokkinos

❮ Previous
Next ❯

Citations

May 7, 2009·Current Opinion in Cardiology·Konstantinos TziomalosDimitri P Mikhailidis
Nov 25, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Peter J OldenburgJoseph H Sisson
Jan 17, 2007·Ageing Research Reviews·Genovefa D Kolovou, Katherine K Anagnostopoulou
Mar 11, 2008·The American Journal of Medicine·Dana E KingMark E Geesey
Apr 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Sandra CappelloMaria Carmela Cerra
Feb 9, 2012·Postgraduate Medicine·Jeffrey T Kirchner
Apr 16, 2020·Expert Review of Endocrinology & Metabolism·Brian TomlinsonChristopher Wai Kei Lam
Jan 27, 2009·Revista de saúde pública·Maria Cristina Pereira LimaLigia Regina Franco Sansigolo
Dec 5, 2017·International Urology and Nephrology·Mustafa Zafer TemizAtilla Semercioz
Dec 31, 2020·Healthcare·Yusuf S AlthobaitiMohammad N Uddin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.